SODIUM VALPROATE
SpainMedications containing this active substance
-
Depakine 100 mg/ml powder and solvent for solution for injection
Form: powder and solvent for solution for injection
Active substance Dosage SODIUM VALPROATE 400 mg Manufacturer: Sanofi Aventis S.A.
-
Depakine 200 mg gastro-resistant tablets
Form: tablets, enteric-coated
Active substance Dosage SODIUM VALPROATE 200 mg Manufacturer: Sanofi Aventis S.A.
-
Depakine 200 mg/ml oral solution
Form: solution, oral
Active substance Dosage SODIUM VALPROATE 20 g Manufacturer: Sanofi Aventis S.A.
-
Depakine 500 mg enteric-coated tablets
Form: tablets, enteric-coated
Active substance Dosage SODIUM VALPROATE 500 mg Manufacturer: Sanofi Aventis S.A.
-
Depakine Chrono 300 mg prolonged-release tablets
Form: tablets, prolonged-release
Active substance Dosage VALPROIC ACID 87 mg SODIUM VALPROATE 200 mg Manufacturer: Sanofi Aventis S.A.
-
Depakine Chrono 500 mg prolonged-release tablets
Form: tablets, prolonged-release
Active substance Dosage VALPROIC ACID 145 mg SODIUM VALPROATE 333 mg Manufacturer: Sanofi Aventis S.A.
-
Valproic acid Altan 400 mg powder for solution for injection EFG
Form: powder for solution for injection
Active substance Dosage SODIUM VALPROATE 400 mg Manufacturer: Altan Pharmaceuticals Sa
-
Valproic acid Aurovitas 300 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage SODIUM VALPROATE 199.80 mg VALPROIC ACID 87.00 mg Manufacturer: Aurovitas Spain, S.A.U.
-
Valproic acid Aurovitas 500 mg prolonged-release tablets EFG
Form: tablets, prolonged-release
Active substance Dosage SODIUM VALPROATE 333.00 mg VALPROIC ACID 145.00 mg Manufacturer: Aurovitas Spain, S.A.U.
-
Valproic acid Seacross 100 mg/ml solution for injection and infusion
Form: solution for injection and for infusion
Active substance Dosage SODIUM VALPROATE 100 mg/ml Manufacturer: Seacross Pharma (Europe) Limited